Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Tumori|January 6, 2022
Anthracycline, taxane, and trastuzumab-based neoadjuvant chemotherapy in HER2-positive early breast cancer: phase II trialBenedetta Conte, Filippo Montemurro, Alessia Levaggi, et al.
Clinical Medicine Insights. Reproductive Health|August 9, 2019
Potential Mechanisms of Ovarian Protection with Gonadotropin-Releasing Hormone Agonist in Breast Cancer Patients: A ReviewFrancesca Poggio, Matteo Lambertini, Claudia Bighin, et al.
ESMO Open|June 27, 2018
Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysisFrancesca Poggio, Marco Bruzzone, Marcello Ceppi, et al.
Anticancer Research|July 2, 2014
Incidence of hepatitis in patients with evidence of past or current hepatitis B or C during chemotherapy for early breast cancerAlessia Levaggi, Andrea De Maria, Beatrice Dozin, et al.
European Journal of Clinical Investigation|June 15, 2020
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreakMarco Tagliamento, Francesco Spagnolo, Francesca Poggio, et al.
JCO Oncology Practice|June 24, 2020
Assessing the Impact of the COVID-19 Outbreak on the Attitudes and Practice of Italian Oncologists Toward Breast Cancer Care and Related Research ActivitiesFrancesca Poggio, Marco Tagliamento, Massimo Di Maio, et al.
Breast (Edinburgh, Scotland)|May 21, 2024
"Positioning of tucatinib in the new clinical scenario of HER2-positive metastatic breast cancer: An Italian and Spanish consensus paper"Pierfranco Conte, Eva Ciruelos, Giuseppe Curigliano, et al.
Breast Cancer Research and Treatment|November 3, 2021
Safety of systemic hormone replacement therapy in breast cancer survivors: a systematic review and meta-analysisFrancesca Poggio, Lucia Del Mastro, Marco Bruzzone, et al.
Cancer Treatment Reviews|December 24, 2013
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trialsLucia Del Mastro, Marcello Ceppi, Francesca Poggio, et al.
Current Oncology (Toronto, Ont.)|May 24, 2024
Multidisciplinary and Tailored Treatment of Locally Advanced Breast Cancer in Progression during Neoadjuvant Chemotherapy: Case ReportLetizia Cuniolo, Marco Gipponi, Federica Murelli, et al.
Pageof 7